Empiric Antibiotic Selection for Postoperative Wound Infections

1. General Recommendations by Surgical Site

Trunk or extremity wounds (away from axilla/perineum): First‑line agents are oxacillin, nafcillin, cefazolin, or cefalexin to cover Staphylococcus aureus and coagulase‑negative staphylococci, the predominant skin‑flora pathogens.  1
Alternative MRSA coverage for trunk/extremity wounds: When local epidemiology or patient risk factors suggest MRSA, add sulfamethoxazole‑trimethoprim or vancomycin.  1
Intestinal or genitourinary surgery wounds: Preferred single‑drug regimens are piperacillin‑tazobactam or a carbapenem (imipenem, meropenem, or ertapenem) to provide broad aerobic‑and‑anaerobic coverage.  1
Combination options for intestinal/genitourinary wounds: Ceftriaxone + metronidazole or a fluoroquinolone (ciprofloxacin or levofloxacin) + metronidazole can be used when a carbapenem is not desired.  1
Additional gram‑negative enhancement: Ampicillin‑sulbactam combined with an aminoglycoside (gentamicin or tobramycin) offers extra coverage against resistant gram‑negative organisms.  1
Axilla or perineum wounds: Ceftriaxone or a fluoroquinolone together with metronidazole is recommended to address the polymicrobial mix of aerobic and anaerobic bacteria typical of these sites.  1

Empiric regimen: Include agents active against Pseudomonas aeruginosa—piperacillin‑tazobactam, ceftazidime, cefepime, aztreonam, or a carbapenem—because gram‑negative and polymicrobial infections are increasingly reported when vancomycin powder is used prophylactically.  1

First‑line therapy: An aminopenicillin plus β‑lactamase inhibitor (amoxicillin‑clavulanate or ampicillin‑sulbactam) administered intravenously (2 g every 8 h) for a maximum of 48 hours.  4
Targeted pathogens: Staphylococci (S. aureus, S. epidermidis), Enterobacteriaceae, and anaerobic bacteria are the usual culprits.  4
β‑lactam allergy alternative: Vancomycin 30 mg/kg/day intravenously (up to 48 hours) provides coverage for MRSA and other gram‑positive organisms.  4

Indications for adding MRSA‑active agents (vancomycin, linezolid, daptomycin, or ceftaroline): documented MRSA colonization, recent re‑operation in a unit with MRSA prevalence, recent systemic antibiotic exposure, or β‑lactam allergy.  4
Vancomycin dosing guideline: 30 mg/kg based on actual body weight, infused over 120 minutes.  8
Alternative MRSA agents: Linezolid, clindamycin, daptomycin, ceftaroline, doxycycline, or sulfamethoxazole‑trimethoprim may be selected according to infection severity and anatomical site.  1

Duration of treatment: Unlike prophylaxis (limited to 24–48 hours), therapeutic courses should be individualized based on the patient’s clinical response and infection severity.  5
Avoid using prophylactic regimens for established infection: A single dose of cefazolin, appropriate for prophylaxis, is insufficient for treating active wound infections.  5
Ensure anaerobic coverage for GI/GU or perineal wounds: Omitting metronidazole or a β‑lactamase inhibitor combination markedly increases the risk of treatment failure.  1